ALEXANDER SNYDER. For Profit or For Health? It is Time to Reckon With the Current Pharmaceutical Landscape Through a Systematic Analysis of Monoclonal Anitbodies. Pittsburgh Journal of Technology Law & Policy, [S. l.], v. 21, n. 2, 2021. DOI: 10.5195/tlp.2021.251. Disponível em: https://tlp.law.pitt.edu/ojs/tlp/article/view/251. Acesso em: 10 aug. 2022.